Steven E. Nissen, MD, lead author of the study “Bempedoic Acid And Cardiovascular Outcomes In Statin-Intolerant Patients,” answers questions on the importance of his team’s research on bempedoic acid, how...
In this video, Paul M. Ridker, MD, MPH, discusses his team's recent study, which found that vascular inflammation levels in patients on statin therapy are better predictors of future cardiovascular events...
Gulsen Ozen, MD, answers questions about her team’s research in the use of statins to help reduce the risk of cardiovascular disease and type 2 diabetes in individuals with rheumatoid arthritis.
The medical community is uniquely positioned to help combat the spread of medical misinformation. Now that online groups opposed to proven medical interventions are taking aim at statins, here is what...
James Matera, DO, discusses how lipid disorders impact the management of chronic kidney disease (CKD), and whether statins are safe for use in patients with comorbid lipid disorders and CKD.
One of the many benefits of statins is their use as a primary prevention for cardiovascular disease. In this Q&A, Jiang Bian, PhD, and Yi Guo, PhD, answered our questions about the associations of...
Robert Rosenson, MD, from Mount Sinai - New York, talks to us about statin-related adverse events related to muscles and what you should do if your patient presents with such events.
